Table 1 Patient characteristics
From: Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity
| Â | N | Â |
|---|---|---|
Age, mean (SD) | 97 | 12.9 (3.2) |
Age- Pubertal (10+ years), n (%) | 97 | 81 (83.5) |
Male, n (%) | 97 | 42 (43.3) |
Race, n (%) | ||
 White | 80 | 66 (82.5) |
 Black | 80 | 6 (7.5) |
 Arab | 80 | 6 (7.2) |
 Aboriginal | 80 | 4 (5) |
 South Asia | 80 | 3 (3.8) |
BMI z score, mean (SD) | 97 | 3.8 (1.4) |
Comorbidities, n(%) | ||
 Type 2 diabetes | 84 | 0(0.0) |
 NAFLD | 84 | 49 (58.3) |
 Sleep apnea | 83 | 14 (16.9) |
 Pre-existing acanthosis nigricans | 79 | 44 (55.7) |
Blood levels | ||
 Total Cholesterol (mmol/L), mean (SD) | 97 | 4.4 (0.8) |
 Triglycerides (mmol/L), median (IQR) | 96 | 1.3 (0.8–1.9) |
 HDLC (mmol/L), median (IQR) | 97 | 1.0 (0.9–1.2) |
 LDLC, mean (SD) | 96 | 2.6 (0.7) |
 Non HDL Cholesterol (mmol/L), mean (SD) | 84 | 3.3 (0.8) |
 HOMAIR +3.16, n(%) | 95 | 50 (52.6) |
 ALT (IU/mL), median (IQR) | 97 | 26.0 (17.0–33.5) |
 AST(IU/mL), median (IQR) | 95 | 26.0 (21.0–30.0) |
 Adiponectin, median (IQR) | 96 | 11.3 (7.5–19.3) |
 NAFLD grading by US, n(%) | 97 |  |
 Normal |  | 29 (29.9) |
 Mild |  | 37 (38.1) |
 Moderate |  | 19 (19.6) |
 Severe |  | 12 (12.4) |